Design of experiment avenue for development and validation of RP-HPLC-PDA method for determination of apremilast in bulk and in in-house tablet formulation
Abstract Background Apremilast is phosphodiesterase-4 and an immunomodulating agent used for treatment of refractory psoriatic arthritis. Methods The reversed-phase high-performance liquid-chromatography method for analysis of apremilast was developed and validated as per ICH guidelines. The separat...
Main Authors: | Suraj R. Chaudhari, Atul A. Shirkhedkar |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-02-01
|
Series: | Journal of Analytical Science and Technology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40543-019-0170-8 |
Similar Items
-
Development and Validation of Rapid RP-HPLC and Green Second-Derivative UV Spectroscopic Methods for Simultaneous Quantification of Metformin and Remogliflozin in Formulation Using Experimental Design
by: Mahesh Attimarad, et al.
Published: (2020-10-01) -
An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation
by: Bhaskaran Navya Ajitkumar, et al.
Published: (2021-03-01) -
Simvastatin assay and dissolution studies by feasible RP-HPLC in tablets
by: Flávia Dias Marques-Marinho, et al.
Published: (2012-01-01) -
Optimized chronomodulated dual release bilayer tablets of fexofenadine and montelukast: quality by design, development, and in vitro evaluation
by: Bhupendra Singh, et al.
Published: (2019-10-01) -
Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
by: Anvesha Ganorkar, et al.
Published: (2020-06-01)